Sentara Infusion Services: Drug Recall
Recall #D-0315-2023 · 12/27/2022
Class II: Risk
Recall Details
- Recall Number
- D-0315-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Sentara Infusion Services
- Status
- Completed
- Date Initiated
- 12/27/2022
- Location
- Chesapeake, VA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 78 bags
Reason for Recall
Lack of sterility assurance
Product Description
PIPERACILLIN / TAZOBACTAM (a) 4.5GM IN NS 100 ML, (b)18GM IN NS 267M, (c) 27GM IN NS 400ML, (d) 3.375 GM IN NS 50ML, (e) 36 GM IN NS 533 ML, antibiotic, Rx only, use with a Curlin or home pump or no pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
Distribution Pattern
Dispensed to Patients Nationwide.
Other Recalls by Sentara Infusion Services
- Class II: Risk 12/27/2022
- Class II: Risk 12/27/2022
- Class II: Risk 12/27/2022
- Class II: Risk 12/27/2022
- Class II: Risk 12/27/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.